METASTATIC RENAL CELL CARCINOMA ( MRCC)
Clinical trials for METASTATIC RENAL CELL CARCINOMA ( MRCC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA ( MRCC) trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA ( MRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for untreated kidney cancer patients in pfizer trial
Disease control Recruiting nowThis study is testing a new medicine called PF-08634404 for adults with advanced kidney cancer that has spread. Researchers want to see if the medicine is safe and effective when given alone or with other cancer drugs. The study is recruiting 224 adults who haven't received any t…
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
Could a Scan-Guided drug holiday ease the burden of kidney cancer treatment?
Disease control Recruiting nowThis study is testing if a special type of scan (PET/CT) can safely tell doctors when to pause treatment for people with advanced kidney cancer. It is for patients who have responded well to at least a year of standard drug therapy. The goal is to see if a closely monitored break…
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Apr 01, 2026 21:55 UTC
-
Three-Pronged attack: new combo aims to stop spreading kidney cancer
Disease control Recruiting nowThis study is testing a three-part treatment for people whose advanced kidney cancer has started to spread again in a few spots. It combines a drug injected into a tumor to activate the immune system, very precise radiation to those spreading spots, and continued immunotherapy. T…
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for advanced kidney cancer patients in experimental drug trial
Disease control Recruiting nowThis study is testing two new drug combinations for advanced kidney cancer that has spread or cannot be surgically removed. It will compare these experimental treatments against the current standard therapy in 120 patients who haven't received any previous cancer drugs. The main …
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Phase: PHASE2 • Sponsor: Brian Rini • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Global hunt for better kidney cancer treatment clues
Knowledge-focused Recruiting nowThis international study is looking back at medical records to understand how different combination treatments work for advanced kidney cancer that has spread. Researchers will analyze data from over 1,200 patients who have already received specific drug combinations. The goal is…
Matched conditions: METASTATIC RENAL CELL CARCINOMA ( MRCC)
Sponsor: Hospital of Macerata • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC